Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Factors affecting postmortem blood concentrations
Family, improving medication adherence
Fatal Toxicity Index
Fatigue multiple sclerosis psychostimulants to reduce in depression
Fentanyl dependence, buprenorphine low-dose induction
Financial incentives, improving adherence
First-choice agents prescribed for tardive dyskinesia (αbetical order; no preference implied)
first-generation antipsychotics (FGAs)
Fish oils mild/moderate depressions in older adults dyslipidaemia treatment
Flowchart for naloxone administration.
Fluid restriction, hyponatraemia treatment
Flumazenil induction by antidepressants Acutely disturbed or violent behaviour
flunitrazepam, concentration in normal dosing and UK legal limit
Fluoxetine bipolar depression bulimia nervosa in pregnancy autism spectrum disorder borderline personality disorder depression/bipolar disorder suicidality in children and adolescents
Flupentixol bipolar disorder long-acting injections doses and frequencies borderline personality disorder pharmacokinetics
Fluphenazine, smokers
Fluxoxamine for tardive dyskinesia for antipsychotic-induced weight gain smokers
forms T2 and T3, Mental Health Act
Formulations of drugs impaired absorption following bariatric surgery problems with tablets when tapering
Factors affecting adherence
Factors associated with antipsychotic-induced pneumonia
fasting plasma glucose (FPG) test
Fatal Toxicity Index (FTI), antidepressants
Ferritin in blood, psychotropic agent effects
Findings of meta-analyses of the risk of pathological blood clotting
First-Episode Schizophrenia
Fixed-dose regimens, benzodiazepines for alcohol withdrawal management
Flow chart for the use of covert medication.
Flumazenil, guidelines for use of
forms T4/T5/T6, Mental Health Act